Insights

DEA, HHS extend telehealth controlled substance prescribing flexibilities for fourth time

The extension, released shortly before the flexibilities were set to expire at the end of 2025, gives regulators more time to finish permanent policies, the agencies said.

Red full article here.

CONTACT US